Pricing Log in Create free account

Accuray Incorporated (ARAY) vs HeartSciences Inc. (HSCS)

Accuray Incorporated and HeartSciences Inc. are both Medical Devices companies. Accuray Incorporated is the larger, with a market value of $14.8M against $13.3M — 1.1× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against −12.5%. Accuray Incorporated has the higher net margin (−4.41% vs −48,621.8%) and the lower return on invested capital (−21.8% vs 0.00%). Across the 17 metrics below, Accuray Incorporated leads on 10 and HeartSciences Inc. on 7.

Valuation

Metric ARAY HSCS Medical Devices median
P/E n/m n/m 24.94
P/S 0.04 488.61 2.66
P/B 0.29 n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 0.17 519.02 2.76
Earnings yield (136.36%) (114.59%) (12.66%)
Free cash flow yield (178.40%) (69.02%) (7.18%)

Profitability

Metric ARAY HSCS Medical Devices median
Gross margin 0.00% 18.01% 57.76%
Operating margin (13.09%) (44,918.48%) (14.84%)
Net margin (4.41%) (48,621.80%) (14.45%)
Free cash flow margin (6.86%) (33,725.12%) (5.70%)
Return on equity (30.23%) (1,854.69%) (10.56%)
Return on assets (4.10%) (201.67%) (17.26%)
Return on invested capital (21.79%) 0.00% (5.22%)

Growth

Metric ARAY HSCS Medical Devices median
Revenue growth (TTM) (12.50%) 131.87% 10.41%
EPS growth (last fiscal year) (2,480.65%) 62.74% 28.17%
Revenue growth, 5-year CAGR 0.28% (30.01%) 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARAY HSCS Medical Devices median
Debt to equity 1.79 0.00 0.04
Current ratio 1.56 0.14 2.67
Net debt to EBITDA (10.10) 0.21 0.54

Dividend

Metric ARAY HSCS Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric ARAY HSCS Medical Devices median
Market cap 14.82m 13.26m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack